Skip to main content

Table 5 Cox regression analysis to assess risk of anti-HCV seroconversion in patients undergoing hemodialysis therapy*

From: Infection by the hepatitis C virus in chronic renal failure patients undergoing hemodialysis in Mato Grosso state, central Brazil: a cohort study

Risk Factors N (%) Anti-HCV + (%) Adjusted Hazard Ratio (CI95%) P
Time on HDT*     
   Up to 4 years 269 (74.7) 25 (62.5) 1 -
   > 4 years 91 (25.3) 15 (37.5) 2.2 (1.1–4.6) 0.027
Unit Groups     
   A (4,5,6) 201 (55.8) 2 (5) 1 -
   B (1,2,3) 159 (44.2) 38 (95) 42.4 (9.9–180.5) 0.000
  1. *Adjusted by transfusion, number of transfusions, age group, and gender.
  2. **HDT: hemodialysis therapy.